Partnershipprimary sourcedetected 2026-06-12 · confidence 95%
Simcere Pharmaceutical Group Limited: Partnership
Simcere Pharmaceutical entered into a research collaboration agreement with Stanford Medicine to develop innovative therapies for Idiopathic Pulmonary Fibrosis, expanding its respiratory therapeutic pipeline.
Source: PRN — Business Technology
The leadership read
Need for Clinical Development Director, Head of Respiratory Program, Regulatory Affairs Manager, Medical Affairs roles, and potentially R&D leadership to support collaboration execution and IPF program advancement.
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Asia signal share is easing (-2.1pts).